As Director of Clinical Development and Medical Affairs at Boehringer Ingelheim Pharmaceuticals Inc., Dr. Wang recognizes the importance of having the opportunity to train the next generation of clinical researchers and to expose them to opportunities outside of academia. Her current position at BIPI and former positions as Senior Director of Clinical Research at Replidyne Inc and Vice President of Clinical Development at Sanofi Pasteur afford her the ability to offer trainees the industry perspective of clinical research and insights into the drug development process.
At the same time, Dr. Wang is well acquainted with conducting research at an academic institution. Earlier in her career, I had a primary appointment as Associate Professor in Pediatrics and cross appointment at the Institute of Health Policy, Management and Evaluation (IHPME) at the Hospital for Sick Children and the University of Toronto. Her academic research examined diagnostic evaluation, prognostic markers, and interventions in respiratory infections, particularly those due to respiratory syncytial virus (RSV).